[go: up one dir, main page]

DE60034966D1 - Auswertung von biologischen mitteln in lebenden zielzellen - Google Patents

Auswertung von biologischen mitteln in lebenden zielzellen

Info

Publication number
DE60034966D1
DE60034966D1 DE60034966T DE60034966T DE60034966D1 DE 60034966 D1 DE60034966 D1 DE 60034966D1 DE 60034966 T DE60034966 T DE 60034966T DE 60034966 T DE60034966 T DE 60034966T DE 60034966 D1 DE60034966 D1 DE 60034966D1
Authority
DE
Germany
Prior art keywords
target cells
biological agents
evaluation
living target
living
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034966T
Other languages
English (en)
Inventor
Manuel Vega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nautilus Biotech SA
Original Assignee
Nautilus Biotech SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nautilus Biotech SA filed Critical Nautilus Biotech SA
Application granted granted Critical
Publication of DE60034966D1 publication Critical patent/DE60034966D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60034966T 1999-12-16 2000-12-13 Auswertung von biologischen mitteln in lebenden zielzellen Expired - Lifetime DE60034966D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915884A FR2802645B1 (fr) 1999-12-16 1999-12-16 Methode d'evaluation de la performance d'un ensemble d'agents biologiques dans des cellules cibles vivantes et ses applications
PCT/FR2000/003503 WO2001044809A2 (fr) 1999-12-16 2000-12-13 Evaluation d'agents biologiques dans des cellules cibles vivantes

Publications (1)

Publication Number Publication Date
DE60034966D1 true DE60034966D1 (de) 2007-07-05

Family

ID=9553337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034966T Expired - Lifetime DE60034966D1 (de) 1999-12-16 2000-12-13 Auswertung von biologischen mitteln in lebenden zielzellen

Country Status (6)

Country Link
US (1) US20030129584A1 (de)
EP (1) EP1244912B1 (de)
AT (1) ATE363070T1 (de)
DE (1) DE60034966D1 (de)
FR (1) FR2802645B1 (de)
WO (1) WO2001044809A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808804B1 (fr) * 2000-05-09 2002-08-02 Nautilus Biotech Procede de determination du titre d'agents biologiques en temps reel dans des cellules cibles vivantes et ses applications
US7647184B2 (en) 2001-08-27 2010-01-12 Hanall Pharmaceuticals, Co. Ltd High throughput directed evolution by rational mutagenesis
US20030129203A1 (en) * 2001-08-27 2003-07-10 Nautilus Biotech S.A. Mutant recombinant adeno-associated viruses
US20060020396A1 (en) * 2002-09-09 2006-01-26 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
CA2498319A1 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US20050202438A1 (en) * 2002-09-09 2005-09-15 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US20060251619A1 (en) * 2005-05-04 2006-11-09 Gilles Borrelly Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
US20080003202A1 (en) * 2006-03-28 2008-01-03 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
EP2423305A1 (de) * 2006-06-19 2012-02-29 Catalyst Biosciences, Inc. Modifizierte Gerinnungsfaktor-IX-Polypeptide und deren Verwendung bei der Behandlung
WO2008065372A2 (en) 2006-11-28 2008-06-05 Nautilus Biotech, S.A. Modified erythropoietin polypeptides and uses thereof for treatment
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
US10943676B2 (en) 2010-06-08 2021-03-09 Cerner Innovation, Inc. Healthcare information technology system for predicting or preventing readmissions
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method

Also Published As

Publication number Publication date
FR2802645B1 (fr) 2002-03-08
WO2001044809A3 (fr) 2001-12-20
US20030129584A1 (en) 2003-07-10
WO2001044809A2 (fr) 2001-06-21
FR2802645A1 (fr) 2001-06-22
ATE363070T1 (de) 2007-06-15
EP1244912A2 (de) 2002-10-02
EP1244912B1 (de) 2007-05-23

Similar Documents

Publication Publication Date Title
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
ATE397752T1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
WO2004041865A3 (en) Stabilized single domain antibodies
DE60237194D1 (de) Plattform für protein-profiling
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
DE69813158D1 (de) Assays zur Bestimmung von Proteinfragmenten in biologischen Medien
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
DK0692025T3 (da) Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf
DK1025227T3 (da) Humane TOLL-homologer
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
ATE312178T1 (de) Infektiöse pseudovirale papillomavirus partikel
DE60114018D1 (de) Von zellen präsentierte peptide
WO1999047639A3 (en) Staphylococcus aureus genes and polypeptides
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
DK0960336T3 (da) Peptidreagens til påvisning af humant cytomelagovirus (CMV)
WO2002048403A3 (en) Multiplexed protein expression and activity assay
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
AU4908799A (en) Determination of the hydrophobic pulmonary surfactant protein sp-c
BR0010222A (pt) Vetores de expressão viral
ATE267253T1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung

Legal Events

Date Code Title Description
8332 No legal effect for de